Mercadolibre Inc (MELI) 146.22 $MELI MercadoLibre Set to

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 4:05 PM

Mercadolibre Inc (MELI) 146.22 $MELI

MercadoLibre Set to Possibly Pullback After Yesterday's Rally of 1.90%
Comtex SmarTrend(R) - Thu Jul 07, 3:41PM CDT
MercadoLibre (NASDAQ:MELI) traded in a range yesterday that spanned from a low of $140.53 to a high of $143.59. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $142.35 on volume of 139,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MELI: 146.22 (+3.30)

Uptrend Call Working As MercadoLibre Stock Rises 37.5% (MELI)
Comtex SmarTrend(R) - Mon Jun 13, 1:12PM CDT
SmarTrend identified an Uptrend for MercadoLibre (NASDAQ:MELI) on February 17th, 2016 at $97.31. In approximately 4 months, MercadoLibre has returned 37.53% as of today's recent price of $133.82.
MELI: 146.22 (+3.30)

39.1% Return Seen to Date on SmarTrend MercadoLibre Call (MELI)
Comtex SmarTrend(R) - Fri Jun 03, 1:03PM CDT
SmarTrend identified an Uptrend for MercadoLibre (NASDAQ:MELI) on February 17th, 2016 at $97.31. In approximately 4 months, MercadoLibre has returned 39.12% as of today's recent price of $135.37.
MELI: 146.22 (+3.30)

MercadoLibre Shares Up 35.1% Since SmarTrend's Buy Recommendation (MELI)
Comtex SmarTrend(R) - Thu May 19, 1:05PM CDT
SmarTrend identified an Uptrend for MercadoLibre (NASDAQ:MELI) on February 17th, 2016 at $97.31. In approximately 3 months, MercadoLibre has returned 35.09% as of today's recent price of $131.45.
MELI: 146.22 (+3.30)

PetMed (PETS) Tops Q4 Earnings and Revenue Expectations
Zacks Equity Research - Zacks Investment Research - Wed May 11, 6:05AM CDT
PetMed Express, Inc. (PETS) announced earnings per share (EPS) of 27 cents in the fourth quarter of fiscal 2016, up 8% from the year-ago quarter.
AMZN: 745.81 (+9.24), PETS: 19.24 (+0.28), MELI: 146.22 (+3.30), IAC: 57.03 (+0.92)

GoDaddy (GDDY) Incurs Lower-than-Expected Loss in Q1
Zacks Equity Research - Zacks Investment Research - Mon May 09, 8:55AM CDT
GoDaddy's (GDDY) first-quarter 2016 adjusted loss of 15 cents per share came in lower than the Zacks Consensus Estimate of a loss of 18 cents.
AMZN: 745.81 (+9.24), TVPT: 13.21 (+0.22), MELI: 146.22 (+3.30), GDDY: 30.72 (+0.70)

SmarTrend Watching for Potential Pullback in Shares of MercadoLibre After 1.76% Gain
Comtex SmarTrend(R) - Fri May 06, 1:54PM CDT
MercadoLibre (NASDAQ:MELI) traded in a range yesterday that spanned from a low of $123.42 to a high of $131.00. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $127.06 on volume of 461,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MELI: 146.22 (+3.30)

Alibaba (BABA) Lags Q4 Earnings Estimates, Tops Revenues
Zacks Equity Research - Zacks Investment Research - Fri May 06, 10:14AM CDT
Alibaba Group Holding Limited (BABA) reported fourth-quarter fiscal 2016 (ended Mar 31, 2016) earnings of 20 cents per share, missing the Zacks Consensus Estimate of 38 cents. The adjusted figure excludes one-time items but includes stock-based compensation expense.
AMZN: 745.81 (+9.24), TVPT: 13.21 (+0.22), MELI: 146.22 (+3.30), BABA: 78.99 (-0.36)

MercadoLibre, Inc. Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 05, 3:03PM CDT
38.3 million Sold Items, up 39%, 27.5 million Total Payment Transactions, up 86%
MELI: 146.22 (+3.30)

Better Buy Now: eBay vs MercadoLibre
Andrés Cardenal, The Motley Fool - Motley Fool - Thu May 05, 11:04AM CDT
IMAGE SOURCE: EBAY. MercadoLibre is sometimes described as the eBay of Latin America, and this comparison makes a lot of sense. Not only is eBay a major shareholder in MercadoLibre, with an 18% stake in the company, but the two e-commerce...
AMZN: 745.81 (+9.24), EBAY: 24.61 (+0.68), MELI: 146.22 (+3.30)

The Zacks Analyst Blog Highlights: Amazon.com, eBay, Alibaba, Mercadolibre and Travelport Worldwide
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:30AM CDT
The Zacks Analyst Blog Highlights: Amazon.com, eBay, Alibaba, Mercadolibre and Travelport Worldwide
AMZN: 745.81 (+9.24), EBAY: 24.61 (+0.68), TVPT: 13.21 (+0.22), MELI: 146.22 (+3.30), BABA: 78.99 (-0.36)

Priceline Earnings Top Estimates, Guidance Disappoints
Sejuti Banerjea - Zacks Investment Research - Wed May 04, 1:43PM CDT
Priceline.com (PCLN) reported first quarter results that beat the Zacks Consensus Estimate on revenue and earnings but missed on guidance.
TVPT: 13.21 (+0.22), GRPN: 3.40 (+0.06), MELI: 146.22 (+3.30), PCLN: 1,329.46 (+32.20)

MercadoLibre Has Returned 28.1% Since SmarTrend Recommendation (MELI)
Comtex SmarTrend(R) - Wed May 04, 1:14PM CDT
SmarTrend identified an Uptrend for MercadoLibre (NASDAQ:MELI) on February 17th, 2016 at $97.31. In approximately 3 months, MercadoLibre has returned 28.08% as of today's recent price of $124.63.
MELI: 146.22 (+3.30)

E-Commerce Stocks Reporting Earnings on May 5: BABA, MELI, TVPT
Zacks Equity Research - Zacks Investment Research - Wed May 04, 10:41AM CDT
A few e-commerce companies are slated to report their earnings results on May 5.
AMZN: 745.81 (+9.24), EBAY: 24.61 (+0.68), TVPT: 13.21 (+0.22), EXPE: 109.43 (+1.86), MELI: 146.22 (+3.30), BABA: 78.99 (-0.36)

Can Priceline (PCLN) Stock Post an Earnings Surprise This Q1?
Sejuti Banerjea - Zacks Investment Research - Mon May 02, 3:19PM CDT
Priceline (PCLN) is slated to report first quarter earnings results on May 4 after the bell.
TVPT: 13.21 (+0.22), MELI: 146.22 (+3.30), PCLN: 1,329.46 (+32.20)

Is Mercadolibre Inc. a Buy?
Brian D. Pacampara, CFA, The Motley Fool - Motley Fool - Fri Apr 29, 4:48PM CDT
IMAGE SOURCE: MERCADOLIBRE Shares of Latin American e-commerce giant Mercadolibre are on a nice run of late, up about 30% over the past three months (versus a gain of 11% on the S&P 500). Of course, much of that outperformance has been...
EBAY: 24.61 (+0.68), MELI: 146.22 (+3.30)

Expedia (EXPE) Shares Soar on Record Revenue Growth, Earnings Beat
Sejuti Banerjea - Zacks Investment Research - Fri Apr 29, 12:48PM CDT
Expedia Inc. (EXPE) shares gained 10.8% in extended trading yesterday, as quarterly revenue growth was the strongest in several years and earnings estimates were also beaten by a wide margin.
TVPT: 13.21 (+0.22), EXPE: 109.43 (+1.86), MELI: 146.22 (+3.30), SIMO: 52.20 (+1.81)

Amazon Smashes 1Q Earnings Estimates, AWS Still The Star
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 10:59AM CDT
Amazon.com (AMZN) beat both revenue and earnings estimates in the first quarter.
AMZN: 745.81 (+9.24), TVPT: 13.21 (+0.22), GOOGL: 717.78 (+10.52), MELI: 146.22 (+3.30)

MercadoLibre, Inc. to Report First Quarter 2016 Financial Results
GlobeNewswire - Thu Apr 28, 5:01PM CDT
MercadoLibre, Inc. (Nasdaq:MELI) (http://www.mercadolibre.com) intends to release financial results for its first fiscal quarter ended March 31, 2016 on May 5th, 2016 after the close of the day's trading.
MELI: 146.22 (+3.30)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...